NCT02553772 - A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease. | Biotech Hunter

Enrollment

242

Participants

Timeline

Start Date

January 6, 2016

Primary Completion Date

September 9, 2016

Study Completion Date

September 9, 2016

Conditions

Dry Eye Syndromes

Interventions

DRUG

Carboxymethylcellulose Based Eye Drop

Carboxymethylcellulose based eye drop (OM3 Tear) administered as 1-2 drops in each eye, as needed, at least 2 times daily for 90 days.

DRUG

Carboxymethylcellulose Sodium 0.5%

Carboxymethylcellulose sodium 0.5% (REFRESH OPTIVE® ADVANCED) administered as 1-2 drops in each eye, as needed, at least 2 times daily for 90 days.

Trial Locations (13)

Rochester Ophthalmological Group, PC, Rochester

Scott and Christie and Associate, Cranberry Township

Charlotte Eye Ear Nose, Charlotte

Ophthalmology Associates, St Louis

Moyes Eye Center, PC, Kansas City

Texan Eye, Austin

Lugene Eye Institute, Glendale

Havana Research Institute LLC, Burbank

The Private Practice of Milton Hom, OD, Azusa

Eric M. White, OD, INC, San Diego

Department of Optometry & Vision Sciences, The University of Melbourne, Parkville

Prof. M.T. Coroneo Pty. Ltd., Randwick

The University of New South Wales School of Optometry and Vision Science, Sydney